Business Description
Shanghai Haohai Biological Technology Co Ltd
ISIN : CNE100001W69
Share Class Description:
FRA:5HB: Shs -H- Unitary 144A/Reg STotal Employee Number:
2,110Compare
Compare
Traded in other countries / regions
06826.Hong Kong688366.China5HB.Germany IPO Date
2015-05-06Description
Shanghai Haohai Biological Technology Co Ltd is engaged in the manufacturing and sale of biologicals, medical hyaluronate, and ophthalmology products. The Company's operating activities are related to a single operating segment, which is the manufacture and sale of biologicals, medical hyaluronate, and intraocular lenses, research and development of biological engineering and pharmaceutical products, and the provision of related services. Its products are categorized into four types, comprising ophthalmology, medical aesthetics, orthopedics, and anti-adhesion. Geographically, it has operations in Mainland China, which is the key revenue driver, the United States, the United Kingdom, and other countries.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 7.84 | |||||
Equity-to-Asset | 0.82 | |||||
Debt-to-Equity | 0.06 | |||||
Debt-to-EBITDA | 0.98 | |||||
Interest Coverage | 11.44 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 5.03 | |||||
Beneish M-Score | -2.38 | |||||
WACC vs ROIC | ||||||
Growth Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 6.4 | |||||
3-Year EBITDA Growth Rate | 2.5 | |||||
3-Year EPS without NRI Growth Rate | 6.3 | |||||
3-Year Book Growth Rate | 1.6 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 58.36 | |||||
9-Day RSI | 43.41 | |||||
14-Day RSI | 36.55 | |||||
3-1 Month Momentum % | -16.67 | |||||
6-1 Month Momentum % | -23.08 | |||||
12-1 Month Momentum % | -27.54 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.73 | |||||
Quick Ratio | 3.14 | |||||
Cash Ratio | 2.66 | |||||
Days Inventory | 347.75 | |||||
Days Sales Outstanding | 60.64 | |||||
Days Payable | 46.31 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 7.24 | |||||
Dividend Payout Ratio | 1.02 | |||||
3-Year Dividend Growth Rate | 25.1 | |||||
Forward Dividend Yield % | 7.24 | |||||
5-Year Yield-on-Cost % | 17.5 | |||||
3-Year Average Share Buyback Ratio | 2.5 | |||||
Shareholder Yield % | 7.1 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 68.62 | |||||
Operating Margin % | 10.22 | |||||
Net Margin % | 6.6 | |||||
EBITDA Margin % | 18.66 | |||||
FCF Margin % | -11.47 | |||||
OCF Margin % | 1.11 | |||||
ROE % | 2.07 | |||||
ROA % | 1.65 | |||||
ROIC % | 3.5 | |||||
3-Year ROIIC % | -50.11 | |||||
ROC (Joel Greenblatt) % | 5.71 | |||||
ROCE % | 1.95 | |||||
Years of Profitability over Past 10-Year | 10 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 29.05 | |||||
Forward PE Ratio | 7.09 | |||||
PE Ratio without NRI | 37.49 | |||||
Shiller PE Ratio | 9.38 | |||||
PEG Ratio | 7.5 | |||||
PS Ratio | 1.9 | |||||
PB Ratio | 0.58 | |||||
Price-to-Tangible-Book | 0.68 | |||||
Price-to-Operating-Cash-Flow | 172.39 | |||||
EV-to-EBIT | 39.59 | |||||
EV-to-Forward-EBIT | 29.86 | |||||
EV-to-EBITDA | 14.3 | |||||
EV-to-Forward-EBITDA | 19.79 | |||||
EV-to-Revenue | 2.67 | |||||
EV-to-Forward-Revenue | 5.61 | |||||
EV-to-FCF | -23.3 | |||||
Price-to-GF-Value | 0.67 | |||||
Price-to-Projected-FCF | 0.84 | |||||
Price-to-DCF (Earnings Based) | 3.19 | |||||
Price-to-Peter-Lynch-Fair-Value | 2.97 | |||||
Price-to-Graham-Number | 1.06 | |||||
| Price-to-Net-Current-Asset-Value | 1.46 | |||||
| Price-to-Net-Cash | 2.65 | |||||
Earnings Yield (Greenblatt) % | 2.53 | |||||
FCF Yield % | -2.98 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shanghai Haohai Biological Technology Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 210.604 | ||
| EPS (TTM) (€) | 0.06 | ||
| Beta | 0.4597 | ||
| 3-Year Sharpe Ratio | -0.29 | ||
| 3-Year Sortino Ratio | -0.41 | ||
| Volatility % | 32.21 | ||
| 14-Day RSI | 36.55 | ||
| 14-Day ATR (€) | 0.039632 | ||
| 20-Day SMA (€) | 1.7405 | ||
| 12-1 Month Momentum % | -27.54 | ||
| 52-Week Range (€) | 1.66 - 3.24 | ||
| Shares Outstanding (Mil) | 224.98 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shanghai Haohai Biological Technology Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shanghai Haohai Biological Technology Co Ltd Stock Events
| Event | Date | Price (€) | ||
|---|---|---|---|---|
| HKD 0.688247 Cash Dividend | 2026-06-04 | 2.00 (+0.00%) | ||
| HKD 0.438462 Cash Dividend | 2025-09-05 | 2.98 (+3.47%) | ||
| HKD 0.655029 Cash Dividend | 2025-06-17 | 2.86 (+0.00%) | ||
| HKD 0.438670 Cash Dividend | 2024-09-20 | 3.42 (+0.00%) | ||
| 1.4:1 Stock Split | 2024-06-06 | 3.43 (+0.00%) |
Show
Entries
Shanghai Haohai Biological Technology Co Ltd Frequently Asked Questions
What is Shanghai Haohai Biological Technology Co Ltd(FRA:5HB)'s stock price today?
The current price of FRA:5HB is €1.72. The 52 week high of FRA:5HB is €3.24 and 52 week low is €1.66.
When is next earnings date of Shanghai Haohai Biological Technology Co Ltd(FRA:5HB)?
The next earnings date of Shanghai Haohai Biological Technology Co Ltd(FRA:5HB) is .
Does Shanghai Haohai Biological Technology Co Ltd(FRA:5HB) pay dividends? If so, how much?
The Dividend Yield %  of Shanghai Haohai Biological Technology Co Ltd(FRA:5HB) is 7.24% (As of Today), Highest Dividend Payout Ratio of Shanghai Haohai Biological Technology Co Ltd(FRA:5HB) was 1.04. The lowest was 0.17. And the median was 0.24. The  Forward Dividend Yield % of Shanghai Haohai Biological Technology Co Ltd(FRA:5HB) is 7.24%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Articles on Shanghai Haohai Biological Technology Co Ltd
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers